Nirma acquires majority stake in Glenmark Life Sciences
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today
It is the first autotaxin inhibitor to be investigated in cancer patients
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
Women emerge as the cornerstone of this monumental undertaking
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
The investment will catalyse various components of the IndiaAI Mission
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters
ANVISA issues CGMP to Concord Biotech’s Unit I
Subscribe To Our Newsletter & Stay Updated